Cellyan Biotechnology Co., Ltd (HKPD)Healthcare | Pharmaceutical Retailers | Yau Tong, Hong Kong | NasdaqCM
0.73 USD
+0.03
(4.286%)
⇧
(April 17, 2026, 4 p.m.
EDT)
Short-term: ★☆☆☆☆ | Long-term: ★☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 11, 2026, 2:57 p.m. EDT
HKPD shows a highly volatile price history with a recent dip from a peak of 0.68 to 0.51, followed by a slight recovery. The stock has a negative profit margin, negative earnings growth, and poor revenue growth, indicating weak financial performance. The stock is currently trading below its 50-day and 200-day moving averages, suggesting a bearish trend. The lack of dividend history and the low dividend rating make it unsuitable for income-focused investors. The forecasting model predicts a significant price drop in the next 45 days, which raises concerns about short-term momentum. Long-term investors should be cautious due to the company's poor fundamentals and lack of consistent earnings. Overall, HKPD is not a recommended investment at this time. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.120473 |
| AutoETS | 0.175788 |
| AutoARIMA | 0.175973 |
| MSTL | 0.185869 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 42% |
| H-stat | 16.67 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.503 |
| Excess Kurtosis | -0.86 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 44.186 |
| Revenue per Share | 1.528 |
| Market Cap | 17,154,990 |
| Profit Margins | -4.29% |
| Previous Name | Hong Kong Pharma Digital Technology Holdings Limited |
| Website | https://www.9zt.hk |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.2505353 |
| Address1 | Well Town Industrial Building |
| Address2 | Room B1, 5th Floor 13 Ko Fai Road |
| All Time High | 3.79 |
| All Time Low | 0.37 |
| Ask | 0.9488 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 20,530 |
| Average Daily Volume3 Month | 40,263 |
| Average Volume | 40,263 |
| Average Volume10Days | 20,530 |
| Bid | 0.511 |
| Bid Size | 2 |
| Book Value | 0.468 |
| City | Yau Tong |
| Country | Hong Kong |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.73 |
| Current Ratio | 2.927 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 0.7395 |
| Day Low | 0.6801 |
| Debt To Equity | 44.186 |
| Display Name | Cellyan Biotechnology |
| Earnings Growth | -0.831 |
| Earnings Quarterly Growth | -0.814 |
| Ebitda | -534,478 |
| Ebitda Margins | -0.03267 |
| Enterprise To Ebitda | -14.634 |
| Enterprise To Revenue | 0.478 |
| Enterprise Value | 7,821,350 |
| Eps Trailing Twelve Months | -0.06 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 0.66338 |
| Fifty Day Average Change | 0.06661999 |
| Fifty Day Average Change Percent | 0.10042508 |
| Fifty Two Week Change Percent | -25.053532 |
| Fifty Two Week High | 2.76 |
| Fifty Two Week High Change | -2.03 |
| Fifty Two Week High Change Percent | -0.73550725 |
| Fifty Two Week Low | 0.37 |
| Fifty Two Week Low Change | 0.36 |
| Fifty Two Week Low Change Percent | 0.972973 |
| Fifty Two Week Range | 0.37 - 2.76 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,736,951,400,000 |
| Float Shares | 7,355,370 |
| Free Cashflow | 2,435,613 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 27 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.08804 |
| Gross Profits | 1,440,320 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.62258 |
| Held Percent Institutions | 0.00364 |
| Implied Shares Outstanding | 23,499,986 |
| Industry | Pharmaceutical Retailers |
| Industry Disp | Pharmaceutical Retailers |
| Industry Key | pharmaceutical-retailers |
| Ipo Expected Date | 2,025-01-15 |
| Language | en-US |
| Last Fiscal Year End | 1,743,379,200 |
| Long Business Summary | Cellyan Biotechnology Co., Ltd, an investment holding company, engages in the over the counter (OTC) pharmaceutical business in Hong Kong and Mainland China. The company provides OTC pharmaceutical cross-border procurement and distribution and e-commerce supply chain services. It also offers custom clearance, drugs enlisting, warehouse, and other logistics services. The company serves e-commerce platform logistics partners, merchants, and pharmaceutical distributors. The company was formerly known as Hong Kong Pharma Digital Technology Holdings Limited and changed its name to Cellyan Biotechnology Co., Ltd in December 2025. Cellyan Biotechnology Co., Ltd was incorporated in 2023 and is based in Yau Tong, Hong Kong. |
| Long Name | Cellyan Biotechnology Co., Ltd |
| Market | us_market |
| Market Cap | 17,154,990 |
| Market State | POSTPOST |
| Max Age | 86,400 |
| Message Board Id | finmb_1877183498 |
| Most Recent Quarter | 1,759,190,400 |
| Name Change Date | 2,026-04-16 |
| Net Income To Common | -701,880 |
| Next Fiscal Year End | 1,774,915,200 |
| Non Diluted Market Cap | 16,449,990 |
| Open | 0.6832 |
| Operating Cashflow | -427,922 |
| Operating Margins | 0.02963 |
| Payout Ratio | 0.0 |
| Phone | 852 2618 9289 |
| Prev Name | Hong Kong Pharma Digital Technology Holdings Limited |
| Previous Close | 0.7 |
| Price Hint | 4 |
| Price To Book | 1.5598291 |
| Price To Sales Trailing12 Months | 1.0486083 |
| Profit Margins | -0.0429 |
| Quick Ratio | 2.507 |
| Quote Source Name | Delayed Quote |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.03 |
| Regular Market Change Percent | 4.28572 |
| Regular Market Day High | 0.7395 |
| Regular Market Day Low | 0.6801 |
| Regular Market Day Range | 0.6801 - 0.7395 |
| Regular Market Open | 0.6832 |
| Regular Market Previous Close | 0.7 |
| Regular Market Price | 0.73 |
| Regular Market Time | 1,776,456,001 |
| Regular Market Volume | 13,319 |
| Return On Assets | -0.03938 |
| Return On Equity | -0.13375 |
| Revenue Growth | -0.357 |
| Revenue Per Share | 1.528 |
| Sand P52 Week Change | 0.36506534 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 16,349,986 |
| Shares Percent Shares Out | 0.0 |
| Shares Short | 380 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 2,676 |
| Short Name | Cellyan Biotechnology Co., Ltd |
| Short Percent Of Float | 0.0001 |
| Short Ratio | 0.01 |
| Source Interval | 15 |
| Symbol | HKPD |
| Total Cash | 2,481,334 |
| Total Cash Per Share | 0.226 |
| Total Debt | 2,272,684 |
| Total Revenue | 16,359,769 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.06 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 1.00708 |
| Two Hundred Day Average Change | -0.27707994 |
| Two Hundred Day Average Change Percent | -0.27513203 |
| Type Disp | Equity |
| Volume | 13,319 |
| Website | https://www.9zt.hk |
| Zip | 999,077 |